Farrow Financial »

Lineage Cell Therapeutics In shares owned by Farrow Financial

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Farrow Financial from 13F filings

Historical chart of Farrow Financial investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Farrow Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Farrow Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $17k 12k 1.48
2023-12-31 $19k 17k 1.09

More positions owned by Farrow Financial

Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)
Ishares Tr Msci Usa Esg Slc (SUSA)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Ishares Tr Blackrock Ultra (ICSH)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Badger Meter (BMI)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
Intel Corporation (INTC)
MasTec (MTZ)
Vulcan Materials Company (VMC)

View all positions for Farrow Financial

Top funds holding Lineage Cell Therapeutics In

BlackRock
Vanguard Group
Logos Global Management
Defender Capital
Geode Capital Management
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
DAFNA Capital Management
Bank of America Corporation
Northern Trust
Bridgeway Capital Management
Jpmorgan Chase & Co
Nuveen Asset Management
Morgan Stanley

View all funds holding Lineage Cell Therapeutics In